Template for Reporting Results of Biomarker Testing of Specimens From Patients With Melanoma.

Authors Lynette M. Sholl, MD, FCAP* Department of Pathology, Brigham and Women's Hospital, Boston, Massachusetts Aleodor Andea, MD, MBA, FCAP Department of Pathology, University of Michigan Hospitals, Ann Arbor, Michigan Julia Bridge, MD, FCAP Department of Pathology, University of Nebraska Medical Center, Omaha, Nebraska Liang Cheng, MD, FCAP Department of Pathology, Indiana University, Indianapolis, Indiana Michael A. Davis MD, PhD Departments of Melanoma Medical Oncology and Systems Biology, The University of Texas MD Anderson Cancer Center, Houston, Texas Mani Ehteshami, MD, MS, FCAP Newport Coast Pathology Inc, Newport Beach, California Tara C. Gangadhar, MD Department of Medicine and the Abramson Cancer Center, Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania Suzanne Kamel-Reid, PhD, FACMG Department of Pathology, The University Health Network/Princess Margaret Cancer Center, Toronto, Ontario Alexander Lazar, MD, PhD, FCAP Departments of Pathology and Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas Kirtee Raparia, MD, FCAP Department of Pathology, Northwestern University, Chicago, Illinois Alan Siroy, MD, MPH Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas Kim Watson, CTR Cancer Registry Consultant, Sioux Falls, South Dakota